What is Barclays's price target for CVS?

Barclays's latest stated price target for CVS Health Corporation (CVS) is $82, from its action on Oct 10, 2024.

What is Barclays's rating on CVS?

Barclays rates CVS Overweight, a bullish rating, as of Oct 10, 2024.

When did Barclays last change its view on CVS?

On Oct 10, 2024, Barclays upgrades to Overweight from Equal Weight, price target $63 to $82.

Barclays CVS price target and rating history

CVS Health Corporation (CVS) · Consumer Staples

Barclays rates CVS Health Corporation (CVS) Overweight with a $82 price target, as of its latest action on Oct 10, 2024. It has published 3 rating actions on CVS since November 2021, including 1 upgrade and 0 downgrades.

Current rating: Overweight
Price target: $82
Median target, all firms: Too few
Actions on CVS: 3

Barclays price target on CVS

Barclays price target on CVS, each point a stated target, November 2021 to October 2024.

Every Barclays rating on CVS

Oct 10, 2024
UpgradeBarclays upgrades to Overweight from Equal Weight, price target $63 to $82
Mar 6, 2024
InitiateBarclays starts coverage at Equal Weight, price target $78
Nov 4, 2021
ReiterateBarclays raises its price target to $110 from $100, keeps Overweight

Questions about Barclays and CVS

What is Barclays's price target for CVS?: Barclays's latest stated price target for CVS Health Corporation (CVS) is $82, from its action on Oct 10, 2024.
What is Barclays's rating on CVS?: Barclays rates CVS Overweight, a bullish rating, as of Oct 10, 2024.
When did Barclays last change its view on CVS?: On Oct 10, 2024, Barclays upgrades to Overweight from Equal Weight, price target $63 to $82.

More CVS rating histories

All Barclays ratings CVS news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.